March 2025
1. LI Y, Ma XM, Jia JG, Cao LY, et al
   Association between metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction subtypes and risk of colorectal cancer: A Prospective Cohort Study.
   Clin Res Hepatol Gastroenterol. 2025 Mar 15:102573.
   

   >> Share

   
   January 2025
2. DABOUT V, Mineur L, Tougeron D, Malicot KL, et al
   Induction triplet chemotherapy in patients with rectal adenocarcinoma and synchronous metastases, an AGEO-FFCD study.
   Clin Res Hepatol Gastroenterol. 2025;49:102514.
   

   >> Share

   
   November 2024
3. WANG J, Zhang X, Chen K, Liang Y, et al
   Optimization of endoscopic treatment strategies for R0 resection of rectal neuroendocrine tumors smaller than 10 mm.
   Clin Res Hepatol Gastroenterol. 2024;48:102469.
   

   >> Share

   
   October 2024
4. GOMEZ CIFUENTES JD, Berger S, Thrift AP, Ketwaroo G, et al
   Baylor College of Medicine (BCM) model predicts recurrence after mucosectomy of colorectal lateral spreading tumors in European cohorts.
   Clin Res Hepatol Gastroenterol. 2024;48:102460.
   

   >> Share

   
   September 2024
5. JIN KM, Bao Q, Zhao TT, Wang HW, et al
   Comparing Baseline VAF in Circulating tumor DNA and Tumor Tissues Predicting Prognosis of Patients with Colorectal Cancer Liver Metastases After Curative Resection.
   Clin Res Hepatol Gastroenterol. 2024 Sep 12:102464.
   

   >> Share

   
   August 2024
6. BRAGANCA S, Garcia AC, Alexandrino G, Oliveira AM, et al
   Validation of a novel BCM model for recurrence risk prediction after mucosectomy of colorectal lateral spreading tumors in a European cohort.
   Clin Res Hepatol Gastroenterol. 2024;48:102414.
   

   >> Share

   
   July 2024
7. AL-HAIDERI M
   Silymarin Suppresses Proliferation and PD-L1 expression in Colorectal Cancer Cells and Increases Inflammatory CD8+ Cells in Tumor-Bearing Mice.
   Clin Res Hepatol Gastroenterol. 2024 Jul 22:102425.
   

   >> Share

   
   
8. KOURIE HR, Zouein J, Zalaquett Z, Chebly A, et al
   Liquid biopsy as a tool for KRAS/NRAS/BRAF baseline testing in metastatic colorectal cancer.
   Clin Res Hepatol Gastroenterol. 2024 Jul 13:102417.
   

   >> Share

   
   May 2024
9. CAZENEUVE N, Bouche O, Leger J, Borg C, et al
   Visceral fat and clinical outcome in patients receiving first-line chemotherapy with bevacizumab for metastatic colorectal cancer.
   Clin Res Hepatol Gastroenterol. 2024 May 22:102380.
   

   >> Share

   
   
10. LU H, Wang H, Zhu L, Xu J, et al
    The impact of WeChat online education and care on the mental distress of caregivers and satisfaction of elderly postoperative colorectal cancer patients.
    Clin Res Hepatol Gastroenterol. 2024 May 6:102372.
    

    >> Share

    
    March 2024
11. RAN D, Xin C, Ma Y, Lu Y, et al
    Increased risk of colorectal adenomas with metabolic-associated fatty liver disease components.
    Clin Res Hepatol Gastroenterol. 2024;48:102302.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share